27 Oct - 9 Nov 2022Rights issue
The Danish pharmaceutical company Cessatech A/S specializes in research and development of an analgesic nasal spray for children. Cessatech’s spray is intended to be used in hospitals for acute pain and in connection with medical procedures.
The offer in summary
Record date: 25 October 2022
Subscription period: 27 October - 9 November 2022
Subscription rights: Those who on the record date 25 October 2022 were registered as shareholders have preferential rights to subscribe for new shares in the rights issue. For one (1) existing share held on the record date the holder receives one (1) unit right. Four (4) unit rights entitle the subscription for one (1) unit. One (1) unit consists of six (6) shares and three (3) warrants of series TO2.
Subscription price: 12,00 DKK
Emission volume: 1.528.133 units
Trading with rights: 25 October - 7 November 2022
Marketplace: Spotlight Stock Market
Financial advisor: Translution Capital